Swiss Life Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $81.5M | Buy |
1,414,008
+210,875
| +18% | +$12.1M | 0.34% | 57 |
|
|
2026
Q1 | $73M | Buy |
1,203,133
+22,967
| +2% | +$1.34M | 0.36% | 59 |
|
|
2025
Q4 | $63.7M | Buy |
1,180,166
+37,322
| +3% | +$1.8M | 0.32% | 58 |
|
|
2025
Q3 | $51.5M | Buy |
1,142,844
+68,565
| +6% | +$3.2M | 0.27% | 75 |
|
|
2025
Q2 | $49.7M | Buy |
1,074,279
+136,063
| +15% | +$6.68M | 0.29% | 71 |
|
|
2025
Q1 | $57.2M | Buy |
938,216
+47,022
| +5% | +$2.74M | 0.42% | 53 |
|
|
2024
Q4 | $50.4M | Buy |
891,194
+413,983
| +87% | +$23.1M | 0.37% | 55 |
|
|
2024
Q3 | $24.7M | Sell |
477,211
-28,028
| -6% | -$1.31M | 0.28% | 81 |
|
|
2024
Q2 | $21M | Sell |
505,239
-41,345
| -8% | -$1.85M | 0.25% | 88 |
|
|
2024
Q1 | $29.6M | Sell |
546,584
-16,330
| -3% | -$832K | 0.41% | 60 |
|
|
2023
Q4 | $28.9M | Buy |
562,914
+125,511
| +29% | +$6.59M | 0.35% | 54 |
|
|
2023
Q3 | $25.4M | Buy |
437,403
+33,938
| +8% | +$2.08M | 0.39% | 46 |
|
|
2023
Q2 | $25.8M | Sell |
403,465
-44,881
| -10% | -$3.01M | 0.38% | 44 |
|
|
2023
Q1 | $31.1M | Sell |
448,346
-38,598
| -8% | -$2.72M | 0.47% | 34 |
|
|
2022
Q4 | $35.1M | Sell |
486,944
-65,986
| -12% | -$4.98M | 0.59% | 29 |
|
|
2022
Q3 | $39.3M | Sell |
552,930
-8,678
| -2% | -$630K | 0.68% | 21 |
|
|
2022
Q2 | $43.3M | Buy |
561,608
+80,325
| +17% | +$6.12M | 0.7% | 22 |
|
|
2022
Q1 | $35.1M | Buy |
481,283
+14,845
| +3% | +$997K | 0.49% | 36 |
|
|
2021
Q4 | $29.1M | Buy |
466,438
+16,709
| +4% | +$980K | 0.38% | 55 |
|
|
2021
Q3 | $26.6M | Buy |
449,729
+15,416
| +4% | +$1.02M | 0.37% | 58 |
|
|
2021
Q2 | $25.3M | Buy |
434,313
+8,747
| +2% | +$570K | 0.26% | 60 |
|
|
2021
Q1 | $26.9M | Sell |
425,566
-4,523
| -1% | -$281K | 0.38% | 51 |
|
|
2020
Q4 | $26.7M | Buy |
430,089
+115,612
| +37% | +$7.11M | 0.39% | 52 |
|
|
2020
Q3 | $19M | Buy |
314,477
+36,762
| +13% | +$2.21M | 0.28% | 79 |
|
|
2020
Q2 | $16.3M | Sell |
277,715
-54,645
| -16% | -$3.27M | 0.26% | 80 |
|
|
2020
Q1 | $18.5M | Buy |
332,360
+126,835
| +62% | +$7.75M | 0.35% | 67 |
|
|
2019
Q4 | $13.2M | Sell |
205,525
-10,098
| -5% | -$578K | 0.25% | 97 |
|
|
2019
Q3 | $10.9M | Sell |
215,623
-4,582
| -2% | -$215K | 0.14% | 120 |
|
|
2019
Q2 | $9.97M | Buy |
220,205
+78,920
| +56% | +$3.68M | 0.12% | 127 |
|
|
2019
Q1 | $6.74M | Sell |
141,285
-563,008
| -80% | -$28M | 0.09% | 151 |
|
|
2018
Q4 | $36.6M | Sell |
704,293
-41,855
| -6% | -$2.25M | 0.75% | 33 |
|
|
2018
Q3 | $46.3M | Buy |
746,148
+257,317
| +53% | +$15.3M | 0.62% | 40 |
|
|
2018
Q2 | $27.1M | Buy |
488,831
+93,773
| +24% | +$5.06M | 0.4% | 67 |
|
|
2018
Q1 | $25M | Buy |
395,058
+1,346
| +0.3% | +$86.6K | 0.44% | 67 |
|
|
2017
Q4 | $24.1M | Buy |
393,712
+122,827
| +45% | +$7.68M | 0.54% | 61 |
|
|
2017
Q3 | $17.3M | Buy |
270,885
+4,484
| +2% | +$262K | 0.46% | 70 |
|
|
2017
Q2 | $14.8M | Buy |
266,401
+7,311
| +3% | +$398K | 0.38% | 76 |
|
|
2017
Q1 | $14.1M | Buy |
259,090
+38,689
| +18% | +$2.12M | 0.38% | 76 |
|
|
2016
Q4 | $12.9M | Buy |
220,401
+73,920
| +50% | +$4.04M | 0.43% | 76 |
|
|
2016
Q3 | $7.9M | Hold |
146,481
| – | – | 0.27% | 80 |
|
|
2016
Q2 | $10.8M | Hold |
146,481
| – | – | 0.44% | 62 |
|
|
2016
Q1 | $9.36M | Hold |
146,481
| – | – | 0.39% | 71 |
|
|
2015
Q4 | $10.1M | Sell |
146,481
-21,200
| -13% | -$1.4M | 0.45% | 65 |
|
|
2015
Q3 | $9.93M | Buy |
167,681
+34,340
| +26% | +$2.18M | 0.48% | 58 |
|
|
2015
Q2 | $8.87M | Sell |
133,341
-7,358
| -5% | -$485K | 0.31% | 67 |
|
|
2015
Q1 | $9.08M | Buy |
+140,699
| New | +$8.81M | 0.37% | 64 |
|
Other funds holding BMY
Swiss Life Asset Management's BMY Position: Q2 2026 in Review
Swiss Life Asset Management increased its Bristol-Myers Squibb (BMY) stake by 18% in Q2 2026, buying an estimated $12.1M and bringing the position to 1,414,008 shares worth $81.5M. The position accounts for 0.34% of the portfolio, ranked #57.
Swiss Life Asset Management first reported a position in BMY in Q1 2015 and has held it in 46 quarters since. 1,874 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Swiss Life Asset Management held 1,414,008 shares of Bristol-Myers Squibb worth $81.5M as of Q2 2026.
- Swiss Life Asset Management bought 210,875 Bristol-Myers Squibb shares in Q2 2026, an estimated $12.1M.
- Bristol-Myers Squibb made up 0.34% of Swiss Life Asset Management's portfolio in Q2 2026, its #57 holding.
- Swiss Life Asset Management first reported a position in Bristol-Myers Squibb in Q1 2015 and has held it in 46 quarters since.
- 1,874 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.